Group Ct Rx SRL
Group Ct Rx reported total assets of 127,885 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Group Ct Rx shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +721 % Total assets +641 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Group Ct Rx's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
Group Ct Rx's financial analysis
- Solvency80.2%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Group Ct Rx
Group Ct Rx's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.458.558
- VAT number
- BE0799458558
- Peppol
- Registered · 0208:0799458558 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Mar 2023
- Registered office
- 9310 Aalst
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Group Ct Rx (SRL) has been based in Aalst since 2023, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 38,512 € and equity of 102,529 €; its revenue is not published. Its solvency stands at 80.2%, above the median of its sector (75.0%).
Companies similar to Group Ct Rx
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Group Ct Rx
What is the revenue of Group Ct Rx?
Group Ct Rx files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Group Ct Rx?
In Belgium, the VAT number is the company number prefixed with BE: BE0799458558 for Group Ct Rx, if the company is VAT-registered. Its company number (CBE) is 0799.458.558.
Where is the registered office of Group Ct Rx?
According to the CBE register, the registered office of Group Ct Rx is in 9310 Aalst.
What is the equity of Group Ct Rx?
At the close of the 2025 financial year, the equity of Group Ct Rx amounts to 102,529 €, a solvency of 80.2% of total assets.
Who manages Group Ct Rx?
The register lists 1 active mandates at Group Ct Rx. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Group Ct Rx
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →